USPTO serial 76975941
MEDIFLOR
Reviewed by CopyMark Law Group
Reg. 2906109Status 710
- Filing date
- Status date
- Registration date
- Nov 30, 2004
- Examiner
- FINE, STEVEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MEDIFLOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
64293 DARMSTADT 1, DE
64293 DARMSTADT 1, DE
64293 DARMSTADT 1, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brooks R. Bruneau
BROOKS R BRUNEAU MATHEWS, COLLINS, SHEPHERD & GOULD, PA100 THANET CIR STE 306PRINCETON, NJ 08540-3674UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Essential oils for personal use | SECTION 8 - CANCELLED | — |
| 005 | Nutraceuticals and pharmaceuticals for the care, hygiene, protection and treatment of irritated, inflamed and squamous skins, and seborrheic dermatitis, sensitive, greasy or dry skins, acne prone skin, psoriasis and complications thereof; nutraceuticals and pharmaceuticals for the treatment of the hair and of the scalp, namely, medicated hair oil, hair remedies, hair preservation treatment, dandruff cream, hair gel, hair lotion, hair mousse, hair conditioner, hair tonic, hair moisturizer, hair cream and shampoos; pharmaceutical and nutraceutical preparations for reduction of pigmentary marks of the skin; Pharmaceutical and nutraceutical preparations for anti-skin aging; medicated creams, pharmaceutical, nutraceutical and medical preparations for slimming purposes; cosmetic wipes with medicated creams; Pharmaceutical and nutraceutical preparations for skin care; for epidermis disorders, for blood disorders, for respiratory organ disorders, namely, prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, and for the relief of bronchospasms; antibiotics; pharmaceuticals to lower blood glucose levels and for prevention and treatment of diabetes and complications thereof; vitamin preparations; pharmaceutical agents for activating cellular functioning; anti-inflammatory pharmaceuticals agents; pharmaceutical agents for digestive organs; drugs for circulatory organs; cerebral and peripheral anti-ischemic drugs, pharmaceuticals for the prevention and treatment of hypertension, angina pectoris and acute myocardial infarction; drugs for allergies, drugs for central and peripheral nervous system disorders; analgesics, soporifics, tranquilizers; drugs for the prevention and treatment of anxiety disorders, of insomnia; tumor suppressing pharmaceutical agents; syrups for pharmaceutical purposes namely, prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof, for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers; digestives aids, drugs for the prevention and treatment of osteoarthritis and rheumatoid arthritis, disinfectants for hygiene purposes, medical bath preparations, namely bath salts; Medicated ointments, pomades and aromatic preparations, all namely for the prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof, for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers; Dietary substances adapted for medical use, namely, food and herbal supplements, diet pills, medicinal herbs, medicinal infusions comprised of medicinal herbs, sugar for medicical purposes, dietetic and low calorie and sugar freefoods for weight loss and medical purposes, food for babies; medical plasters; wound dressing; dental wax; all purpose disinfectants; preparations for destroying vermin; fungicides; herbicides; herbal teas for medicinal purposes; Herbs and plants for pharmaceutical purposes namely, the prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof, for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers; Plant based pharmaceutical preparations, namely, preparations for the prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 1, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 30, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 7, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 18, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 16, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2003 | FAXX | FAX RECEIVED | — |
| Oct 14, 2003 | FAXX | FAX RECEIVED | — |
| Oct 8, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Sep 3, 2003 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Aug 18, 2003 | CFIT | CASE FILE IN TICRS | — |
| Jul 21, 2003 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jul 21, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2003 | PAPER RECEIVED | — | |
| Mar 12, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2003 | PAPER RECEIVED | — | |
| Jul 29, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2002 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jun 17, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2001 | DOCK | ASSIGNED TO EXAMINER | — |